HOME PAGE BACK ISSUES SUBSCRIBE THE BOARD STATEMENT MORE INFO SEARCH
Rethinking AIDS Editorial Board Members
David Rasnick
David Rasnick PhD. Chief Science Officer, Boveran Inc., Saratoga, CA. PhD in chemistry from Georgia Tech 1978, 25 years experience with proteases and protease inhibitors, worked 20 years in pharmaceutical industry developing protease inhibitors for tissue destroying diseases: cancer, emphysema, arthritis, parasitic diseases; studied AIDS 19 years; former President of Rethinking AIDS: the group for the scientific reappraisal of the HIV hypothesis; former president of International Coalition for Medical Justice; advisor to South African President Thabo Mbeki and a member of his expert AIDS panel, which met in Pretoria and Johannesburg, South Africa, May and July 2000. Most recent scientific publication in the area of AIDS is: "The AIDS Dilemma: Drug Diseases Blamed on a Passenger Virus," P. H. Duesberg and D. Rasnick, Genetica 104, 85-132 (1998).
- 'Inhibitors of Protease Useless Against AIDS' (1996)
- 'Non-Infectious HIV is Pathogenic' (1997)
- 'Blinded by Science' (1997)
- 'The Drug-AIDS Hypothesis' (1997)
- 'The AIDS Dilemma: Drug diseases blamed on a passenger virus' (.pdf version) (1999)
- 'South African AIDS Panel Contributions (2000)